Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition
Seminars in Immunopathology · 2025
DOI: 10.1007/s00281-024-01033-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, 2025. Verfasst von Marie Albrecht und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ma.albrecht@uke.de. Hauptthemen laut MEDLINE: Obesity, Lipid Metabolism, Body Composition, Overweight. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
Overweight and obesity (OWO) are linked to dyslipidemia and low-grade chronic inflammation, which is fueled by lipotoxicity and oxidative stress. In the context of pregnancy, maternal OWO has long been known to negatively impact on pregnancy outcomes and maternal health, as well as to imprint a higher risk for diseases in offspring later in life. Emerging research suggests that individual lipid metabolites, which collectively form the lipidome, may play a causal role in the pathogenesis of OWO-related diseases. This can be applied to the onset of pregnancy complications such as gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDP), which in fact occur more frequently in women affected by OWO. In this review, we summarize current knowledge on maternal lipid metabolites in pregnancy and highlight associations between the maternal lipidome and the risk to develop GDM, HDP and childhood OWO. Emerging data underpin that dysregulations in maternal triglyceride, phospholipid and polyunsaturated fatty acid (PUFA) metabolism may play a role in modulating the risk for adverse pregnancy outcomes and childhood OWO, but it is yet premature to convert currently available insights into clinical guidelines. Well-designed large-scale lipidomic studies, combined with translational approaches including animal models of obesity, will likely facilitate the recognition of underling pathways of OWO-related pregnancy complications and child’s health outcomes, based on which clinical guidelines and recommendations can be updated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ma.albrecht@uke.de.
- Junior Research Center for Reproduction: Sexual and Reproductive Health in Overweight and Obesity (SRHOO), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ma.albrecht@uke.de.
- Hamburg Center for Translational Immunology, University Medical Center Hamburg- Eppendorf, Hamburg, Germany. ma.albrecht@uke.de.
- Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.
- Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Hamburg Center for Translational Immunology, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.
Förderung
- Bundesministerium für Bildung und Forschung
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Albrecht, M., Worthmann, A., Heeren, J., Diemert, A., & Arck, P. C. (2025). Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition. Seminars in Immunopathology. https://doi.org/10.1007/s00281-024-01033-6
Vancouver
Albrecht M, Worthmann A, Heeren J, Diemert A, Arck PC. Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition. Seminars in Immunopathology. 2025. doi:10.1007/s00281-024-01033-6
BibTeX
@article{Albrecht2025,
author = {Albrecht, Marie and Worthmann, Anna and Heeren, Jörg and Diemert, Anke and Arck, Petra Clara},
title = {Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition},
journal = {Seminars in Immunopathology},
year = {2025},
doi = {10.1007/s00281-024-01033-6}
}
EUVIMED